U-Blot® Research Grade Anti-Human CD314/KLRK1/NKG2D Antibody (A49MI)Cat. No. WA1564Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD314/KLRK1/NKG2D Antibody (A49MI)Cat. No. WA1564
U-Blot® Research Grade Anti-Human CD314/KLRK1/NKG2D (CYAD-101)Cat. No. WA1563
U-Blot® Research Grade Anti-Human CD314/KLRK1/NKG2D (CYAD-03)Cat. No. WA1562
U-Blot® Research Grade Anti-Human CD314/KLRK1/NKG2D (CYAD-02)Cat. No. WA1561
U-Blot® Research Grade Anti-Human CD314/KLRK1/NKG2D (CYAD-01)Cat. No. WA1560
U-Blot® Research Grade Anti-Human CD309/VEGFR2 Antibody (BC001)Cat. No. WA1559
U-Blot® Research Grade Anti-Human CD309/KDR/VEGFR-2 Antibody (AT001)Cat. No. WA1558
U-Blot® Research Grade Anti-Human CD309/KDR/VEGFR-2 (UB-925)Cat. No. WA1557
U-Blot® Research Grade Anti-Human CD309/KDR/VEGFR-2 (MSB-0254)Cat. No. WA1556
U-Blot® Research Grade Anti-Human CD309/KDR/VEGFR-2 (ImClone 6.64)Cat. No. WA1555
U-Blot® Research Grade Anti-Human CD309/KDR/VEGFR-2 (IMC-1C11)Cat. No. WA1554
U-Blot® Research Grade Anti-Human CD307e/FCRL5 Antibody (DFRF 4539A)Cat. No. WA1553